Asia Pacific Biomarkers Market worth $26.40 billion by 2030
The Report "Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030" is projected to grow from USD 14.73 billion in 2025 and to reach USD 26.40 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 12.4% during the forecast period.
Browse 708 market data Tables and 56 Figures spread through 506 Pages and in-depth TOC on "Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-biomarkers-market-88837314.html
The Asia Pacific biomarkers market is experiencing growth, driven by the increasing prevalence of chronic diseases, the rapid expansion of biopharmaceutical and clinical trial activities, and the growing adoption of precision medicine across the region.
The safety biomarkers segment accounted for the largest share by type segment in the Asia Pacific biomarkers market in 2024.
The Asia Pacific biomarkers market is bifurcated into safety, efficacy, and validation biomarkers. Efficacy biomarkers are further divided into predictive, surrogate, pharmacodynamic, and prognostic biomarkers. In 2024, safety biomarkers accounted for the largest share of the Asia Pacific biomarkers market. This dominance is due to their essential role in identifying toxicity, organ damage, and adverse drug reactions during preclinical and clinical development. Increasing regulatory emphasis on drug safety, rising R&D investments by pharmaceutical and biotech companies, and the growing number of clinical trials are driving adoption of safety biomarkers to reduce late-stage drug failures and improve overall development efficiency.
The personalized medicines segment is expected to be the fastest-growing in the Asia Pacific biomarkers market, by application.
The Asia Pacific biomarkers market has been segmented by application into clinical diagnostics, drug discovery & development, personalized medicine, clinical research, and other applications. The personalized medicine segment is expected to grow at the highest CAGR during the forecast period, driven by the increasing adoption of precision therapies and biomarker-guided treatment decisions, owing to the growing penetration of precision therapies and biomarker-guided treatment decisions in oncology and chronic diseases. Other factors boosting the segment's growth include the rapid proliferation of genomics and molecular diagnostics infrastructure, rising biopharmaceutical R&D activities, and supportive government initiatives for precision healthcare across the entire ??????region.
China accounted for the largest share of the Asia Pacific biomarkers market in 2024.
The Asia-Pacific biomarkers market is segmented into China, Japan, India, Australia, South Korea, and the rest of Asia-Pacific. China dominated the market in 2024, driven by its large and diverse patient population, rapidly growing biopharmaceutical and diagnostics industries, and an increasing number of clinical trials across oncology, infectious diseases, and chronic conditions. Strong government support for precision medicine initiatives, expanding genomics and molecular diagnostics capabilities, and rising investments by domestic and multinational companies further reinforce China’s leading position in the regional biomarkers market.
Key players in the Asia Pacific biomarkers market include Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), QIAGEN (Germany), JSR Corporation (Japan), WuXi AppTec (China), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Biomarkers Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
